Ledger.Open graph →
SEC Form D · Amendment · filed November 9, 2016

Metacrine, Inc

Offering
$37.8M
Sold
$37.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Ronald Evans · San Diego, CADirectorJ. D. Duebendorfer · New York, NYExecLilly J. Farahnakian · Chicago, ILDirectorAmir Nashat · San Diego, CADirectorEric Stewart · Robinson, ILExec · DirectorKristina Burow · San Diego, CADirectorRobert Adelman · San Diego, CADirectorLawrence C. Mandes · DENVER, CODirectorTrisha Millican · San Diego, CAExecWilliams M. Clark · Austin, TXDirectorAlaina Danley · Grand Cayman, Cayman IslandsDirectorMichael Hylander · San Diego, CAExec · DirectorJames Deters · DENVER, CODirectorRichard Heyman · San Diego, CADirectorMurray Markiles · Sherman Oaks, CADirectorKen Song · San Diego, CAExec · DirectorMatthew Ginsberg · Eugene, ORDirectorDennis Capovilla · Eugene, ORDirectorJerrold C. Miller · DENVER, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗